242 related articles for article (PubMed ID: 20935325)
1. Systemic but asymptomatic transthyretin amyloidosis 8 years after domino liver transplantation.
Koike H; Kiuchi T; Iijima M; Ueda M; Ando Y; Morozumi S; Tomita M; Kawagashira Y; Watanabe H; Katsuno M; Shimoyama Y; Okazaki Y; Kamei H; Sobue G
J Neurol Neurosurg Psychiatry; 2011 Nov; 82(11):1287-90. PubMed ID: 20935325
[TBL] [Abstract][Full Text] [Related]
2. Deposition and passage of transthyretin through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers.
Sousa MM; Ferrão J; Fernandes R; Guimarães A; Geraldes JB; Perdigoto R; Tomé L; Mota O; Negrão L; Furtado AL; Saraiva MJ
Lab Invest; 2004 Jul; 84(7):865-73. PubMed ID: 15122304
[TBL] [Abstract][Full Text] [Related]
3. Transthyretin-derived amyloid deposition on the gastric mucosa in domino recipients of familial amyloid polyneuropathy liver.
Takei Y; Gono T; Yazaki M; Ikeda S; Ikegami T; Hashikura Y; Miyagawa S; Hoshii Y
Liver Transpl; 2007 Feb; 13(2):215-8. PubMed ID: 17029284
[TBL] [Abstract][Full Text] [Related]
4. Progression of transthyretin (TTR) amyloidosis in donors and recipients after domino liver transplantation-a prospective single-center cohort study.
Vollmar J; Schmid JC; Hoppe-Lotichius M; Barreiros AP; Azizi M; Emrich T; Geber C; Schad A; Weyer V; Otto G; Heise M; Mittler J; Birklein F; Lang H; Galle PR; Zimmermann T
Transpl Int; 2018 Nov; 31(11):1207-1215. PubMed ID: 30091268
[TBL] [Abstract][Full Text] [Related]
5. Recipient aging accelerates acquired transthyretin amyloidosis after domino liver transplantation.
Misumi Y; Narita Y; Oshima T; Ueda M; Yamashita T; Tasaki M; Obayashi K; Isono K; Inomata Y; Ando Y
Liver Transpl; 2016 May; 22(5):656-64. PubMed ID: 26600212
[TBL] [Abstract][Full Text] [Related]
6. Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation.
Lladó L; Baliellas C; Casasnovas C; Ferrer I; Fabregat J; Ramos E; Castellote J; Torras J; Xiol X; Rafecas A
Liver Transpl; 2010 Dec; 16(12):1386-92. PubMed ID: 21117248
[TBL] [Abstract][Full Text] [Related]
7. The pathological and biochemical identification of possible seed-lesions of transmitted transthyretin amyloidosis after domino liver transplantation.
Yoshinaga T; Yazaki M; Sekijima Y; Kametani F; Miyashita K; Hachiya N; Tanaka T; Kokudo N; Higuchi K; Ikeda S
J Pathol Clin Res; 2016 Apr; 2(2):72-9. PubMed ID: 27499917
[TBL] [Abstract][Full Text] [Related]
8. Familial amyloidotic polyneuropathy and transthyretin.
Nagasaka T
Subcell Biochem; 2012; 65():565-607. PubMed ID: 23225017
[TBL] [Abstract][Full Text] [Related]
9. Acquired transthyretin amyloidosis after domino liver transplant: Phenotypic correlation, implication of liver retransplantation.
Muchtar E; Grogan M; Dasari S; Kurtin PJ; Gertz MA
J Neurol Sci; 2017 Aug; 379():192-197. PubMed ID: 28716239
[TBL] [Abstract][Full Text] [Related]
10. Amyloid Polyneuropathy and Myocardial Amyloidosis 10 Years after Domino Liver Transplantation from a Patient with a Transthyretin Ser50Arg Mutation.
Matsushima M; Yabe I; Tsuda M; Sakakibara M; Shimamura T; Sasaki H
Intern Med; 2017 Dec; 56(23):3231-3235. PubMed ID: 28943540
[TBL] [Abstract][Full Text] [Related]
11. [Cerebral amyloid angiopathy with familial transthyretin-derived oculoleptomeningeal amyloidosis].
Ikeda SI
Brain Nerve; 2013 Jul; 65(7):831-42. PubMed ID: 23832986
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation in transthyretin-related familial amyloid polyneuropathy.
Stangou AJ; Hawkins PN
Curr Opin Neurol; 2004 Oct; 17(5):615-20. PubMed ID: 15367866
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of familial amyloid polyneuropathy].
Adams D; Samuel D; Slama M
Presse Med; 2012 Sep; 41(9 Pt 1):793-806. PubMed ID: 22341949
[TBL] [Abstract][Full Text] [Related]
14. Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation.
Oshima T; Kawahara S; Ueda M; Kawakami Y; Tanaka R; Okazaki T; Misumi Y; Obayashi K; Yamashita T; Ohya Y; Ihse E; Shinriki S; Tasaki M; Jono H; Asonuma K; Inomata Y; Westermark P; Ando Y
J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):740-6. PubMed ID: 24023270
[TBL] [Abstract][Full Text] [Related]
15. Significant deposition of wild type transthyretin-derived amyloid in the gastrointestinal tract of aged individuals.
Ikeda S; Tojo K; Suzuki-Tsuchiya A; Akamatu T; Hashimoto T; Higuchi K
Amyloid; 2009; 16(3):174-7. PubMed ID: 19626481
[TBL] [Abstract][Full Text] [Related]
16. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
[TBL] [Abstract][Full Text] [Related]
17. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin.
Yazaki M; Tokuda T; Nakamura A; Higashikata T; Koyama J; Higuchi K; Harihara Y; Baba S; Kametani F; Ikeda S
Biochem Biophys Res Commun; 2000 Aug; 274(3):702-6. PubMed ID: 10924339
[TBL] [Abstract][Full Text] [Related]
18. Steady turnover of amyloid fibril proteins in gastric mucosa after liver transplantation in familial amyloid polyneuropathy.
Tsuchiya-Suzuki A; Yazaki M; Sekijima Y; Kametani F; Ikeda S
Amyloid; 2013 Sep; 20(3):156-63. PubMed ID: 23826783
[TBL] [Abstract][Full Text] [Related]
19. Transthyretin familial amyloid polyneuropathy.
Planté-Bordeneuve V; Kerschen P
Handb Clin Neurol; 2013; 115():643-58. PubMed ID: 23931808
[TBL] [Abstract][Full Text] [Related]
20. Recent progress in the understanding and treatment of transthyretin amyloidosis.
Sekijima Y
J Clin Pharm Ther; 2014 Jun; 39(3):225-33. PubMed ID: 24749898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
